Melanotan II: difference between revisions
Diff·revision 7 → 8·11:34, 9 Feb 2025
Difference between revision 7 and revision 8 of Melanotan II. 5 lines changed; the page grew by 655 bytes.
| Revision 7 — 06:49, 26 Jan 2025 API_Aurora (talk) fix a dangling clause 2,703 bytes ±0 | Revision 8 — 11:34, 9 Feb 2025 MolarMassMaeve (talk) move a stray full stop inside the reference 3,358 bytes +655 | ||
|---|---|---|---|
| 20 | Effects on appetite are real and are the reason the compound appears in weight-related discussion, but they are accompanied by every other melanocortin effect at the same time.{{r|cone2005}} | 20 | Effects on appetite are real and are the reason the compound appears in weight-related discussion, but they are accompanied by every other melanocortin effect at the same time.{{r|cone2005}} |
| 21 | 21 | ||
| + | 22 | == Documented harms == | |
| + | 23 | Nausea and vomiting are common and dose-related. Spontaneous erections are a predictable MC4R effect and were the observation that led to the development of bremelanotide.{{r|hadley2005}} | |
| + | 24 | ||
| + | 25 | Dermatological effects are the more consequential. Darkening of existing naevi, appearance of new pigmented lesions, and eruptive naevi have been reported, and there are case reports of melanoma in users. Whether the compound is causal is unestablished: users are self-selected for sun exposure and tanning behaviour, and increased dermatological surveillance in a population that has changed colour will find more lesions.{{r|cardones2009}} | |
| + | 26 | ||
| 22 | == References == | 27 | == References == |
| 23 | {{reflist}} | 28 | {{reflist}} |